Recursion Pharmaceuticals, Inc. RXRX Net Investment in Lease
Net Investment in Lease at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s net investment in lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s net investment in lease?
- Recursion Pharmaceuticals, Inc. (RXRX) reported net investment in lease of $42.82M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s net investment in lease changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s net investment in lease decreased by 19.5% year-over-year, from $53.19M to $42.82M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s net investment in lease?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s net investment in lease has grown at a 8.3% compound annual growth rate (CAGR), from $32.9M to $45.34M.